Quentis Therapeutics' Series A Round

Quentis Therapeutics raised a round of funding on February 27, 2018.

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on de…

Articles about Quentis Therapeutics' Series A Round: